Feasibility of Tracheobronchial Defect Reconstruction Using Allogenic Aortic Patch
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Taiwan University Hospital
About this trial
The investigators investigate the feasibility and safety of using cryopreserved aortic patches for tracheal or bronchial defect repair.
Eligibility criteria
Qualifiers
Congenital tracheal deformities: Includes congenital tracheomalacia, congenital tracheobronchial malformations, complete tracheal rings, etc., with severe clinical symptoms and cases where treatment is recommended after evaluation.
Acquired tracheal stenosis: Includes tracheal narrowing caused by diseases, endotracheal intubation, or postoperative scar tissue, with severe clinical symptoms and cases where treatment is recommended after evaluation.
Tracheal injury or tissue defect caused by trauma or burns: Cases requiring surgical repair.
Tracheal tumors: Reconstruction of tracheal tissue following the removal of benign or malignant tumors.
Disqualifiers
Patients who are unable to provide informed consent.
Pulmonary tumors that can be treated with standard lobectomy.
Locally invasive tumors that are unresectable.
Presence of contralateral lymph node metastasis.
Trial design
Treatments tested in this trial
- Cryopreserved aortic patch
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov